Our Network of Trial Sites

Taken together the TAP and IMPACT networks have recruited more than 2,000 patients to practice informing drug and transplant studies led by UK investigators, resulting in high impact publications which have informed clinical practice worldwide. They play an important role in accelerating patient access to innovative therapies and incrementally improve standards of care..

ACT can provide immediate access to this comprehensive network of 27 established research sites across the UK embedded within the NHS. The geographical distribution ensures a diverse and representative demographic of patients with a catchment population of over 20 million.

The TAP network specialises in the delivery of trials of new drugs and combinations in haemato-oncology. Since its formation, 23 pioneering trials have opened and accrued more than 1100 patients, generating globally significant results for blood cancer treatment.

ACT funds and has expanded the TAP network from 12 to 15 centres with additional affiliated centres providing extensive geographical coverage of the UK.

Get in touch

ChrisFox-headshot-photo-2022

Prof. Chris Fox
Medical Director

Dr Pramila Krishnamurthy
Deputy Medical Director

Prof. Steven Knapper
Deputy Medical Director

The specialised haematologists leading the studies in each centre are leaders in their field and many are globally recognised experts

The IMPACT network focuses on stem cell transplant (SCT) and cellular therapy trials and is one of only two SCT trials networks globally. Since its inception, 7 trials have opened and accrued more than 900 patients.

ACT funds 12 IMPACT centres and utilises additional affiliated centres spread widely across the UK.

Get in touch

Dr Wendy Ingram
Medical Director

Dr Victoria Potter
Medical Director

TAP and IMPACT Network Funding Call – Applications Now Open

We are delighted to announce a new funding round for the IMPACT Stem Cell Transplant Clinical Trials Partnership and the haemato-oncology Trials Acceleration Programme (TAP).

Funding is available to NHS Trusts or Health Boards of up to £50,000 per year. Funding must be allocated to research nurse support, or other research staff roles to accelerate set-up and delivery of network adopted clinical studies.

The network also provides the following benefits:

Priority access to network adopted commercial clinical trials
Access to national networks of research experts
Regular network meetings for clinical staff and allied health professionals
Funding to attend annual network meetings for up to 3 people per site
Education and training opportunities including the DIDACT Academy for future clinical leaders

This is an open funding call for existing network sites and new sites interested in joining the network. Network membership and funding will be for 3 years from 1^st April 2027 to 31^st March 2030.

Applications must be submitted to info@act4patients.com by 17:00 GMT Friday 30^th October.

The application form and guidance can be downloaded below:

TAP Network